Q3 2022

Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001493152-22-031858

Q3 2022 · 10-Q

Revenue—

Net Income

-$295.27K

N/M vs Q3 2021

EPS Diluted

-$0.01

no prior Q3 2021 on file

Operating Income-$206,210N/M

Operating Cash Flowderived-$127,253—

Same quarter

Metric	Q3 2022	Q3 2021	Q3 2013	Q3 2012
Revenue	—	—	$139.98K	$96.04K
Net Income	-$295.27K	-$331.72K	$8.21M	-$476.36K
EPS Diluted	-$0.01	—	$0.36	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NovelStem International Corp. · CIK 912544 · Engraved from SEC EDGAR